Nyxoah SA Q3 2024 Everything You Need To Know Ahead Of Earnings
NYXH Stock | USD 8.20 0.20 2.50% |
Under 55% of Nyxoah's traders are presently thinking to get in. The analysis of overall sentiment of trading Nyxoah stock suggests that some investors are interested at this time. Nyxoah's investing sentiment shows overall attitude of investors towards Nyxoah.
Nyxoah |
Nyxoah SA is set to release its Q3 2024 earnings on Nov 6, 2024. The consensus estimate for Q3 2024 revenue is 1.49 million, and the earnings are expected to come in at -0.46 per share. The full year 2024s revenue is expected to be 6.2 million and the earnings are expected to be -1.76 per share.
Read at finance.yahoo.com
Nyxoah Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Nyxoah can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Nyxoah Fundamental Analysis
We analyze Nyxoah's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nyxoah using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nyxoah based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Debt To Equity
Debt To Equity Comparative Analysis
Nyxoah is currently under evaluation in debt to equity category among its peers. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Nyxoah Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Nyxoah stock to make a market-neutral strategy. Peer analysis of Nyxoah could also be used in its relative valuation, which is a method of valuing Nyxoah by comparing valuation metrics with similar companies.
Peers
Nyxoah Related Equities
DXR | Daxor | 6.57 | ||||
PDEX | Pro Dex | 4.81 | ||||
KRMD | Repro Med | 3.98 | ||||
MLSS | Milestone Scientific | 2.60 | ||||
NXGL | Nexgel | 1.51 | ||||
UTMD | Utah Medical | 1.04 | ||||
ATRC | AtriCure | 0.76 | ||||
MMSI | Merit Medical | 0.39 | ||||
LMAT | LeMaitre Vascular | 0.82 | ||||
INFU | InfuSystems Holdings | 0.86 | ||||
ZJYL | JIN MEDICAL | 10.38 |
Complementary Tools for Nyxoah Stock analysis
When running Nyxoah's price analysis, check to measure Nyxoah's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nyxoah is operating at the current time. Most of Nyxoah's value examination focuses on studying past and present price action to predict the probability of Nyxoah's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nyxoah's price. Additionally, you may evaluate how the addition of Nyxoah to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |